Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

β-cell replacement therapy, available currently as pancreas or islet transplantation, has developed without a clear definition of graft functional and clinical outcomes. The International Pancreas and Islet Transplant Association and European Pancreas and Islet Transplantation Association held a wor...

Full description

Bibliographic Details
Main Authors: Rickels, MR, Stock, PG, De Koning, EJP, Piemonti, L, Pratschke, J, Alejandro, R, Bellin, MD, Berney, T, Choudhary, P, Johnson, PR, Kandaswamy, R, Kay, TWH, Keymeulen, B, Kudva, YC, Latres, E, Langer, RM, Lehmann, R, Ludwig, B, Markmann, JF, Marinac, M, Odorico, JS, Pattou, F, Senior, PA, Shaw, JAM, Vantyghem, M-C, White, S
Format: Journal article
Language:English
Published: Lippincott, Williams & Wilkins 2018

Similar Items